Join Research!America’s 29th Annual Meeting of Members March 14


Congresswoman Eddie Bernice Johnson (D-TX-30) will be the keynote speaker at Research!America’s 29th Annual Meeting of Members on March 14 from noon to 2 p.m. ET at the Willard InterContinental Hotel in Washington, D.C. The annual meeting will include election of directors, reports from leadership and a panel discussion about mental health.

Rep. Johnson, Ranking Member of the U.S. House Committee on Science, Space and Technology and a member of the Congressional Mental Health Caucus, will share insights from Capitol Hill on issues relevant to our nation’s scientific enterprise.

Experts from across the mental health and neuroscience research continuum will participate in a panel discussion about the latest developments in mental health research, potential new treatment targets, data sharing and areas where science is having some traction.

Panelists include Brandon Staglin, president, One Mind; Linda Brady, Ph.D., director, Division of Neuroscience and Basic Behavioral Science, NIMH, NIH; Kafui Dzirasa, M.D., Ph.D., associate professor of psychiatry and behavioral sciences, Duke Institute for Brain Sciences; and Wayne Drevets, M.D., scientific vice president and disease area leader, mood disorders, Neuroscience Therapeutic Area, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

There is no registration fee for members, however advance registration is necessary. Click here to register.

For those unable to attend in person, the program will be livestreamed here.

Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient